Evaluation of a Virtual Home Dialysis Mentoring Program (Home) (HOME)

May 18, 2022 updated by: Satellite Healthcare

The Investigator plans to establish a virtual platform for home dialysis physician mentoring with the intent to:

  1. Formulate a practical, interactive, virtual curriculum in home dialysis
  2. Provide dedicated video conferences in home dialysis mentorship
  3. Measure knowledge awareness and attitudes towards home dialysis

Study Overview

Detailed Description

Home-based kidney replacement therapy offers enhanced quality of life and clinical advantages compared to conventional in-center hemodialysis. Globally, there is an increased awareness of home dialysis. However, there is a lack of mentoring centers to support new programs and/or nephrologists to initiate and grow home dialysis.1, 2 Critical prerequisites for a successful mentoring relationship include:

  • Established excellence in home dialysis in the mentor center
  • Willingness from both mentors and mentees to participate in the program
  • Engaging, high quality clinical content, including sharing of best practices
  • Lack of system barriers to establish home dialysis
  • Dedicated metrics to measure success of the program

The Investigator plans to establish a virtual platform with the intent to:

  1. Formulate a practical, interactive, virtual curriculum in home dialysis
  2. Provide dedicated video conferences in home dialysis mentorship
  3. Measure knowledge awareness and attitudes towards home dialysis

The Investigator hypothesizes that an effective, sustained mentorship program will increase knowledge and awareness of home dialysis and will ultimately enhance overall home dialysis adoption.

Study Type

Observational

Enrollment (Actual)

40

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • California
      • San Jose, California, United States, 95128
        • Satellite Healthcare, Inc.

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Physicians credentialed at Satellite Healthcare will be eligible to participate along with nephrology fellows from training programs affiliated with credentialed physicians.

Description

Inclusion Criteria:

  • Credentialed physicians at Satellite Healthcare
  • Nephrology fellows at nephrology training program affiliated with Satellite Healthcare credentialed physician

Exclusion Criteria:

  • Any person who does not meet the inclusion criteria

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Cohort
  • Time Perspectives: Prospective

Cohorts and Interventions

Group / Cohort
Virtual Mentoring Program Participants
Physicians credentialed at Satellite Healthcare will be eligible to participate along with nephrology fellows from training programs affiliated with credentialed physicians.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
The change in participants' self-reported knowledge awareness.
Time Frame: through study completion, an average of 1 year
The change in participants' self-reported knowledge awareness (as assessed by self- reported expertise rating).
through study completion, an average of 1 year
The change in participants' perception of home dialysis adoption
Time Frame: through study completion, an average of 1 year
The change in participants' perception of home dialysis adoption as assessed by the percentage of home dialysis patients relative to conventional in-center hemodialysis at baseline versus the end of the study.
through study completion, an average of 1 year

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Number of registered participants
Time Frame: through study completion, an average of 1 year
Number of physicians who register for the program
through study completion, an average of 1 year
Number of participants attending each session
Time Frame: through study completion, an average of 1 year
Number of physicians who participate in each mentoring Session
through study completion, an average of 1 year
Change in the percentage of patients using home dialysis
Time Frame: through study completion, an average of 1 year
Change between baseline and end of study in the number of home dialysis patients
through study completion, an average of 1 year

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 19, 2021

Primary Completion (Actual)

December 31, 2021

Study Completion (Actual)

December 31, 2021

Study Registration Dates

First Submitted

March 9, 2021

First Submitted That Met QC Criteria

March 17, 2021

First Posted (Actual)

March 19, 2021

Study Record Updates

Last Update Posted (Actual)

May 20, 2022

Last Update Submitted That Met QC Criteria

May 18, 2022

Last Verified

May 1, 2022

More Information

Terms related to this study

Other Study ID Numbers

  • SP132_Home

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on End Stage Renal Disease on Dialysis

3
Subscribe